Inflammation of the gut can cause bloating, altered bowel habits, fatigue, and immune dysregulation. Identifying the best probiotic for an inflamed gastrointestinal tract is less about picking a popular brand and more about matching strains and dose to the specific microbial imbalances driving inflammation. Scientific gut microbiome testing enables this targeted approach by revealing deficits (e.g., butyrate producers) and overgrowths (e.g., Proteobacteria) that correlate with inflammatory states.

The first step is diagnostic clarity. Microbiome sequencing of a stool sample can highlight low diversity, reduced short-chain fatty acid (SCFA) producers, or enrichment of pathobionts. With that information, you can choose strains known to support mucosal integrity and immune modulation. For a concise overview of a testing-guided workflow, see <a href='https://innerbuddies-gut-microbiome.github.io/innerbuddies/how-to-reduce-inflammation-and-detox-intestine'>How to Reduce Inflammation and Detox Intestine</a> and <a href='https://innerbuddies-gut-microbiome.github.io/innerbuddies/from-raw-data-to-action-how-innerbuddies-translates-gut-microbiome-analysis-into-personalized-advice'>From Raw Data to Action</a>. A practical example of translating raw data into recommendations is summarized in this write-up: <a href='https://telegra.ph/From-Raw-Data-to-Action-How-InnerBuddies-Translates-Gut-Microbiome-Analysis-Into-Personalized-Advice-12-21'>From Raw Data to Action</a>.

Which strains have the strongest evidence for reducing intestinal inflammation? Research supports several candidates for different roles:

- Faecalibacterium prausnitzii (promotes butyrate production; often supported via prebiotics or synbiotics rather than direct supplementation)
- Bifidobacterium longum subsp. infantis (reduces permeability and immune activation)
- Lactobacillus plantarum 299v and L. rhamnosus GG (modulate cytokines and support barrier function)
- Saccharomyces boulardii (a yeast that aids mucosal immunity and can counter antibiotic-associated diarrhea)
- Escherichia coli Nissle 1917 (nonpathogenic strain used in some ulcerative colitis maintenance studies)

Dose and administration matter. Mild inflammation may respond to modest doses (5–10 billion CFU per strain), while severe disease settings have used much higher multi-strain preparations. Start slowly to reduce transient symptoms like gas or bloating; increase gradually and reassess with symptom tracking and follow-up testing.

Probiotics are one element of a broader therapeutic plan. Digestive enzymes, targeted prebiotics, and anti-inflammatory nutrients can support mucosal repair and encourage beneficial strains to flourish. Microbiome testing can indicate which fibers or enzymes are most likely to be tolerated and effective. For consumers interested in test-driven options, see this resource: <a href='https://www.innerbuddies.com/products/microbiome-test'>InnerBuddies microbiome test</a>.

Clinical context is essential: people with inflammatory bowel disease (IBD) should coordinate probiotic use with their gastroenterologist because efficacy varies by diagnosis and strain. Multi-strain formulations have shown benefit in some ulcerative colitis trials but are not universally effective for Crohn’s disease.

In practice, the “best probiotic” for an inflamed gut is individualized. Use microbiome testing to identify microbial gaps and overgrowths, select strains with mechanistic evidence for anti-inflammatory and barrier-supportive actions, dose conservatively, and reassess with retesting. For a focused resource on probiotic selection and gut-health strategies, consult the targeted article: [best probiotic for gut health](https://www.innerbuddies.com/blogs/gut-health/best-probiotic-for-inflamed-gut).

Keywords: personalized probiotics, gut microbiome testing, probiotics for inflammation, gut healing probiotics, probiotic dosage for gut inflammation.